Protein-based vaccines against SARS-CoV-2 may provide advantages over mRNA-based vaccines
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates | ACS Nano
Altered spike protein makes SARS-CoV-2 variants more infectious - Boston Children's Answers
Outsmarting SARS-CoV-2 by empowering a decoy ACE2 | Signal Transduction and Targeted Therapy
Vaccines | Free Full-Text | Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity - Computational and Structural Biotechnology Journal
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 | Acta Pharmacologica Sinica
A host of mutations could compromise COVID-19 vaccines and antibody therapies
Frontiers | Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
How Furin and ACE2 Interact with the Spike on SARS-CoV-2 - Assay Genie
Frontiers | The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination | NEJM
Frontiers | Antibodies and Vaccines Target RBD of SARS-CoV-2
Predicting Mutational Effects on Receptor Binding of the Spike Protein of SARS-CoV-2 Variants | Journal of the American Chemical Society
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 - ScienceDirect
Capturing the shape-shifting SARS-CoV-2 spike protein - Boston Children's Answers
ACE2 – NIH Director's Blog
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine - eBioMedicine
Vaccines | Free Full-Text | COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response
Flinders targets COVID-19 vaccine – News
IJMS | Free Full-Text | Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways
